This is one of the major divides in breast cancer classification (in addition to the proposed cell of origin of the breast cancer), decided by the “positive or negative” state of ER, PR, as well as a tumor growth promoting receptor called human epidermal growth factor receptor 2 (Her2). The gene discussed is ERBB2; the disease is breast carcinoma.